Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Best

Showing results (231-240 of 503) with videos related to

Pageof 51
Sort By:
Heart, Lung & Circulation|August 4, 2009
The COACH program produces sustained improvements in cardiovascular risk factors and adherence to recommended medications-two years follow-upMichael Jelinek, Margarite J Vale, Danny Liew, et al.
Diabetes Care|May 20, 1998
Do postmenopausal women with NIDDM have a reduced capacity to deposit and conserve lower-body fat?R M Stoney, K Z Walker, J D Best, et al.
American Journal of Hypertension|April 6, 2004
Comparison of arterial assessments in low and high vascular disease risk groupsAndrew M Wilson, David O'Neal, Craig L Nelson, et al.
Diabetes|June 1, 1983
The response of plasma triglyceride, cholesterol, and lipoprotein lipase to treatment in non-insulin-dependent diabetic subjects without familial hypertriglyceridemiaM A Pfeifer, J D Brunzell, J D Best, et al.
Current Biology : CB|April 9, 2002
Circadian programs of transcriptional activation, signaling, and protein turnover revealed by microarray analysis of mammalian cellsGiles E Duffield, Jonathan D Best, Bernhard H Meurers, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 24, 1997
Low-density lipoprotein size, high-density lipoprotein concentration, and endothelial dysfunction in non-insulin-dependent diabetesS F O'Brien, G F Watts, D A Playford, et al.
Bioconjugate Chemistry|August 8, 2008
Synthesis and convenient functionalization of azide-labeled diacylglycerol analogues for modular access to biologically active lipid probesMatthew D Smith, Denghuang Gong, Christopher G Sudhahar, et al.
Current Pharmaceutical Design|November 17, 2004
Lipoproteins and diabetic microvascular complicationsA J Jenkins, K G Rowley, T J Lyons, et al.
Archives of Disease in Childhood|May 1, 1996
Endocrinology and auxology of sibships with non-classical congenital adrenal hyperplasiaF J Cameron, N Tebbutt, J Montalto, et al.
The Australian and New Zealand Journal of Surgery|June 1, 1988
Clinical spectrum of primary empty sella turcicaM A Murphy, R F Ramos, J K Henderson, et al.
Pageof 51

Showing results (231-240 of 503) with videos related to

Sort By:
Pageof 51
Heart, Lung & Circulation|August 4, 2009
The COACH program produces sustained improvements in cardiovascular risk factors and adherence to recommended medications-two years follow-upMichael Jelinek, Margarite J Vale, Danny Liew, et al.
Diabetes Care|May 20, 1998
Do postmenopausal women with NIDDM have a reduced capacity to deposit and conserve lower-body fat?R M Stoney, K Z Walker, J D Best, et al.
American Journal of Hypertension|April 6, 2004
Comparison of arterial assessments in low and high vascular disease risk groupsAndrew M Wilson, David O'Neal, Craig L Nelson, et al.
Diabetes|June 1, 1983
The response of plasma triglyceride, cholesterol, and lipoprotein lipase to treatment in non-insulin-dependent diabetic subjects without familial hypertriglyceridemiaM A Pfeifer, J D Brunzell, J D Best, et al.
Current Biology : CB|April 9, 2002
Circadian programs of transcriptional activation, signaling, and protein turnover revealed by microarray analysis of mammalian cellsGiles E Duffield, Jonathan D Best, Bernhard H Meurers, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 24, 1997
Low-density lipoprotein size, high-density lipoprotein concentration, and endothelial dysfunction in non-insulin-dependent diabetesS F O'Brien, G F Watts, D A Playford, et al.
Bioconjugate Chemistry|August 8, 2008
Synthesis and convenient functionalization of azide-labeled diacylglycerol analogues for modular access to biologically active lipid probesMatthew D Smith, Denghuang Gong, Christopher G Sudhahar, et al.
Current Pharmaceutical Design|November 17, 2004
Lipoproteins and diabetic microvascular complicationsA J Jenkins, K G Rowley, T J Lyons, et al.
Archives of Disease in Childhood|May 1, 1996
Endocrinology and auxology of sibships with non-classical congenital adrenal hyperplasiaF J Cameron, N Tebbutt, J Montalto, et al.
The Australian and New Zealand Journal of Surgery|June 1, 1988
Clinical spectrum of primary empty sella turcicaM A Murphy, R F Ramos, J K Henderson, et al.
Pageof 51